Novo Nordisk is cutting some 9,000 staff across its global operations in a bid to generate around $1.25 billion in annualized savings through 2026.
The layoffs amount to an 11% headcount reduction, according to BMO Capital Markets.
https://www.biospace.com/business/novo-axes-9-000-employees-worldwide-as-new-ceo-makes-good-on-cost-reallocation-promise